TOP STORIES

• REGULATORY MHLW Panel Launches Full Debate on Drug Coverage Reform; LLPs, Biologics, OTC-Like Meds in Focus
  October 17, 2025

• BUSINESS Viatris Snaps Up Japan’s Aculys Pharma, Gains 2 CNS Assets
  October 17, 2025

• BUSINESS Organon Bids Farewell to 1990s Blockbusters Lipovas and Renivace in Japan
  October 16, 2025

• REGULATORY Deeper CEA Price Cuts Mooted for “Cost Increase” Products: FY2026 Reform Debate
  October 16, 2025

• REGULATORY Chuikyo Urges Stricter Pricing Rules for Conditionally Approved Regenerative Medicines
  October 16, 2025

• BUSINESS Kite Looks to Expand Japan CAR-T Footprint, Boosts Supply Infrastructure
  October 15, 2025

• REGULATORY Komeito’s Exit from Ruling Coalition Casts Uncertainty over Japan’s Drug Policy
  October 15, 2025

• REGULATORY MHLW to Clarify Criteria for Japanese PI Waivers through Q&A, Calls for Data-Based Justifications
  October 14, 2025

• REGULATORY GS1 Barcode Adoption Stalls at 40% of Hospitals, Pharmacist Urges Subsidies
  October 10, 2025

• REGULATORY Japan Launches Study on Legal Framework for Patent Linkage System
  October 9, 2025

• REGULATORY Chuikyo Frowns on Industry Calls for Scrapping Huge-Seller Re-Pricing, Spillovers
  October 9, 2025

• BUSINESS NHI-Market Price Gap Likely to Narrow Further in 2025; Will It Drop into 4% Zone?
  October 8, 2025

• BUSINESS Leqembi Iqlik Autoinjector Now Available in US: Eisai/Biogen
  October 8, 2025

• COMMENTARY Inside Eylea - 2: Will a Bio-AG Return after Six Years? Pricing Debate Resumes
  October 7, 2025

• ACADEMIA Japan’s Sakaguchi Wins 2025 Nobel Prize in Medicine
  October 7, 2025

• BUSINESS Pharma Industry Generally Welcomes New LDP Leader Takaichi
  October 7, 2025

• BUSINESS Boehringer Ingelheim Taps Marc Hasson to Lead Japan Operations
  October 7, 2025

• COMMENTARY Inside Eylea - 1: Patent Issues Behind Differences in Biosimilar Indications for AMD and DME
  October 6, 2025

• BUSINESS Moderna Reaffirms Japan Commitment, Denies Downsizing Concerns
  October 3, 2025

• BUSINESS Regeneron Bolsters Japan Oncology Team as Libtayo Gains Ground
  October 3, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• …
• Next ›
• 最終 »